Loading...

Please wait while we retrieve your documents

ARCHIVES

Original Article

3D and 4D printing of personalized dosage forms

Prerna Suman1 Vandana2 Bhavana Singh3 Hema Arya4

1 2 3 4 Sharda school of pharmacy, Sharda University, Uttar Pradesh, India.

Published Online: May-August 2026

Pages: 14-25

Cite this article

No Doi
check update

Abstract

Personalized dosage forms manufactured by 3D and 4D printing have brought changes in the pharmaceutical sector by helping patients with their personalized, individualized treatments. These therapies are known for their great adherence, safety, and effectiveness. It does offer the ability to formulate a personalized dosage form by controlling the dose, shape, and release characteristics. Comparatively with respect to conventional methods, they give significant benefits by tailoring dosage forms to meet patients' needs. This research paper gives you an idea of how 3D and 4D printing are used for formulating personalized dosage forms with the important printing techniques, smart materials, and print-friendly biomaterials used in the development of a responsive drug delivery system with the principles of additive manufacturing. There are various types of dosage forms that can be manufactured, ranging from tablets to microneedles and polypills. This paper also consists of information regarding Advantages, current challenges, and emerging trends, which do include artificial intelligence, digital healthcare manufacturing, and regulatory issues. In short, we can see that 3d and 4D printing technologies ensure the precise enhancement of precision medicine and tailored pharmaceutical manufacturing. future advancement in smart materials, printing techniques, and laws which will enhance the growth/implantation of personalized medicine in clinical and industrial settings.

Previous

References

  • 1. Norman J, Madurawe RD, Moore CMV, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017;108:39–50. doi:10.1016/j.addr.2016.03.001.

  • 2. Jamróz W, Szafraniec J, Kurek M, Jachowicz R. 3D printing in pharmaceutical and medical applications—Recent achievements and challenges. Pharm Res. 2018;35(9):176. doi:10.1007/s11095-018-2454-x.

  • 3. Tan DK, Maniruzzaman M, Nokhodchi A. Advanced pharmaceutical applications of 3D printing technology. Pharmaceutics. 2021;13(8):1244. doi:10.3390/pharmaceutics13081244.

  • 4. Trenfield SJ, Awad A, Madla CM, Hatton GB, Firth J, Goyanes A, et al. Shaping the future: Recent advances of 3D printing in drug delivery and healthcare. Expert Opin Drug Deliv. 2019;16(10):1081–1094. doi:10.1080/17425247.2019.1660318.

  • 5. Goyanes A, Wang J, Buanz A, Martínez-Pacheco R, Telford R, Gaisford S, Basit AW. 3D printing of medicines: Engineering novel oral devices with unique design and drug release characteristics. Mol Pharm. 2015;12(11):4077–4084. doi:10.1021/mp5007419.

  • 6. Awad A, Fina F, Trenfield SJ, Patel P, Goyanes A, Gaisford S, Basit AW. 3D printed medicines: A new branch of digital healthcare. Int J Pharm. 2021;597:120414. doi:10.1016/j.ijpharm.2021.120414.

  • 7. Khalid GM, Michniak-Kohn BB. 3D and 4D printing in pharmaceutical drug delivery systems. J Control Release. 2022;352:595–616.

  • 8. Javaid M, Haleem A. Current status and applications of 4D printing in healthcare. Clin Epidemiol Glob Health. 2020;8(3):681–689.

  • 9. Miao S, Castro N, Nowicki M, Xia L, Cui H, Zhou X, et al. Four-dimensional printing of smart biomedical materials and applications. Mater Today. 2017;20(10):577–591. doi:10.1016/j.mattod.2017.10.015.

  • 10. Gladman AS, Matsumoto EA, Nuzzo RG, Mahadevan L, Lewis JA. Biomimetic 4D printing. Nat Mater. 2016;15(4):413–418. doi:10.1038/nmat4544.

  • 11. Gao B, Yang Q, Zhao X, Jin G, Ma Y, Xu F. 4D bioprinting for biomedical applications. Trends Biotechnol. 2021;39(11):1065–1078. doi:10.1016/j.tibtech.2021.03.002.

  • 12. Basit AW, Gaisford S, editors. 3D Printing of Pharmaceuticals. Cham: Springer; 2018.

  • 13. Melocchi A, Parietti F, Maccagnan S, Ortenzi MA, Antenucci S, Briatico-Vangosa F, et al. Hot-melt extrusion and fused deposition modelling in drug delivery. J Drug Deliv Sci Technol. 2020;57:101683.

  • 14. Azad MA, Olawuni D, Kimbell G, Badruddoza AZM, Hossain MS, Sultana T. Polymers for extrusion-based 3D printing in pharmaceutical applications. Polymers. 2020;12(7):1519. doi:10.3390/polym12071519.

  • 15. Pereira BC, Isreb A, Forbes RT, Dores F, Habashy R, Petit JB, et al. Additive manufacturing in pharmaceutical applications: Recent advances and future directions. Int J Pharm. 2020;586:119594.

  • 16. Goole J, Amighi K. 3D printing in pharmaceutics: A new tool for designing personalized medicines. Int J Pharm. 2016;499(1–2):376–394.

  • 17. Goyanes A, Madla CM, Umerji A, Duran Piñeiro G, Giraldez Montero JM, Lamas Diaz MJ, et al. Automated therapy preparation using pharmaceutical 3D printing. Int J Pharm. 2019;567:118497.

  • 18. ISO/ASTM 52900:2021. Additive Manufacturing—General Principles—Fundamentals and Vocabulary. Geneva: International Organization for Standardization; 2021.

  • 19. World Health Organization. Global Strategy on Digital Health 2020–2025. Geneva: World Health Organization; 2021.

  • 20. Auel T, Mentrup AFC, Oldfield LR, Seidlitz A. 3D printing of pharmaceutical dosage forms: Recent advances and applications. Adv Drug Deliv Rev. 2025;217:115504. doi:10.1016/j.addr.2024.115504.

  • 21. Alenezi EE, Kerimoğlu O, Uğurlu T. A recent review of the utilization of 3D printing in the development and manufacturing of pharmaceutical dosage forms. J Res Pharm. 2025;28(3):828–843.

  • 22. Saleh-Bey-Kinj Z, Heller Y, Socratous G, Christodoulou P. 3D Printing in Oral Drug Delivery: Technologies, Clinical Applications and Future Perspectives in Precision Medicine. Pharmaceuticals. 2025;18(7):973. doi:10.3390/ph18070973.

  • 23. Salama AH. Recent advances in 3D and 4D printing in pharmaceutical technology: Applications, challenges, and future perspectives. Future J Pharm Sci. 2025;11:107. doi:10.1186/s43094-025-00866-8.

  • 24. Jayabal P, Gujjar S, Ostrovidov S, et al. Advances in 3D Printing for Personalized Pharmaceuticals. Polym Adv Technol. 2025;36(12):e70478. doi:10.1002/pat.70478.

  • 25. Alzhrani RF, Fitaihi RA, Majrashi MA, Zhang Y, Maniruzzaman M, et al. Toward a harmonized regulatory framework for 3D-printed pharmaceutical products: the role of critical feedstock materials and process parameters. Drug Deliv Transl Res. 2025;15:4501–4518. doi:10.1007/s13346-025-01966-x

  • 26. . Wang S, Chen X, Han X, Hong X, Li X, Zhang H, Li M, Wang Z, Zheng A. A review of 3D printing technology in pharmaceutics: Technology and applications, now and future. Pharmaceutics. 2023;15(2):416. doi:10.3390/pharmaceutics15020416.

  • 27. Serrano DR, Kara A, Yuste I, Luciano FC, Ongoren B, Anaya BJ, et al. 3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals. Pharmaceutics. 2023;15(2):313. doi:10.3390/pharmaceutics15020313.

  • 28. Lakkala P, Munnangi SR, Bandari S, Repka MA. Additive manufacturing technologies with emphasis on stereolithography 3D printing in pharmaceutical and medical applications: A review. Int J Pharm X. 2023;5:100159. doi:10.1016/j.ijpx.2023.100159.

  • 29. Muhindo D, Elkanayati R, Srinivasan P, Repka MA, Ashour EA. Recent advances in the applications of additive manufacturing (3D printing) in drug delivery: A comprehensive review. AAPS PharmSciTech. 2023;24(2):57. doi:10.1208/s12249-023-02524-9.

  • 30. Tracy T, Wu L, Liu X, Cheng S, Li X. 3D printing: Innovative solutions for patients and pharmaceutical industry. Int J Pharm. 2023;631:122480. doi:10.1016/j.ijpharm.2022.122480.

  • 31. Englezos K, Wang L, Tan ECK, Kang L. 3D printing for personalised medicines: Implications for policy and practice. Int J Pharm. 2023;635:122785. doi:10.1016/j.ijpharm.2023.122785.

  • 32. 3D printing in personalized medicines: A focus on applications of the technology. Mater Today Commun. 2023;35:105875. doi:10.1016/j.mtcomm.2023.105875.

  • 33. 3D Printing in pharmaceutical manufacturing: Current status and future prospects. Mater Today Commun. 2023;36:107987. doi:10.1016/j.mtcomm.2023.107987.

  • 34. Krueger L, Awad A, Basit AW, Goyanes A, Miles JA, Popat A, et al. Clinical translation of 3D printed pharmaceuticals. Nat Rev Bioeng. 2024;2:801–803.

  • 35. Alzhrani RF, Fitaihi RA, Majrashi MA, Zhang Y, Maniruzzaman M, et al. Toward a harmonized regulatory framework for 3D-printed pharmaceutical products: The role of critical feedstock materials and process parameters. Drug Deliv Transl Res. 2025;15:4501–4518. doi:10.1007/s13346-025-01966-x.

Citations

Prerna Suman , Vandana , Bhavana Singh , Hema Arya , “3D and 4D printing of personalized dosage forms”, Indian Journal of Clinical and Medical Research, Volume 01, Issue 02, May-August 2026, PP: 14-25.

Article Metrics

256
Views
0
Citations
PlumX Metrics PlumX Metrics
Dimension Dimension

Licensing

© 2026 The Author(s). Published by Fifth Dimension Research Publication.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

Related Articles in this Issue

Read Article
Read Article
Read Article